Holen Sie sich die Stockscreener-App
9.70
0.10%
-0.01
Handel nachbörslich:
9.57
-0.13
-1.34%
Schlusskurs vom Vortag:
$9.71
Offen:
$9.76
24-Stunden-Volumen:
1.92M
Relative Volume:
0.76
Marktkapitalisierung:
$1.57B
Einnahmen:
$246.03M
Nettoeinkommen (Verlust:
$-32.00M
KGV:
-45.65
EPS:
-0.2125
Netto-Cashflow:
$-16.78M
1W Leistung:
+5.32%
1M Leistung:
+19.16%
6M Leistung:
+112.25%
1J Leistung:
+201.24%
1-Tages-Spanne:
$9.57
$9.97
1-Wochen-Bereich:
$9.11
$10.03
52-Wochen-Spanne:
$2.82
$10.03
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
Firmenname
Xeris Biopharma Holdings Inc
Sektor
Branche
Telefon
844-445-5704
Adresse
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Vergleichen Sie XERS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
9.70 | 1.57B | 246.03M | -32.00M | -16.78M | -0.2125 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-11-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-03-28 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-28 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-21 | Eingeleitet | Jefferies | Buy |
| 2022-04-28 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-17 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2020-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2018-07-16 | Eingeleitet | Jefferies | Buy |
| 2018-07-16 | Eingeleitet | Leerink Partners | Outperform |
| 2018-07-16 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Xeris Biopharma Holdings Inc Aktie (XERS) Neueste Nachrichten
Applying chart zones and confluence areas to Xeris Biopharma Holdings Inc.Trade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Xeris Biopharma (NASDAQ:XERS) Downgraded to Hold Rating by Zacks Research - MarketBeat
Y Intercept Hong Kong Ltd Acquires 291,696 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Is a relief rally coming for Xeris Biopharma Holdings Inc. holdersEarnings Summary Report & AI Driven Price Predictions - newser.com
What high frequency data says about Xeris Biopharma Holdings Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock appeals to dividend investorsGlobal Markets & Weekly Return Optimization Alerts - newser.com
Xeris Biopharma Hits New 52-Week High of $10.03, Up 314.66% - Markets Mojo
Can Xeris Biopharma Holdings Inc. stock maintain operating marginsWeekly Gains Summary & Growth Focused Stock Reports - newser.com
Is Xeris Biopharma Holdings Inc. stock entering bullish territoryJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Is Xeris Biopharma Holdings Inc. (2B30) stock supported by strong fundamentalsWeekly Investment Report & Fast Moving Trade Plans - newser.com
Using R and stats models for Xeris Biopharma Holdings Inc. forecasting2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Xeris Biopharma (XERS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is Xeris Biopharma Holdings Inc. stock undervalued vs historical averagesWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Can Xeris Biopharma Holdings Inc. stock maintain growth trajectoryJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com
How sentiment analysis helps forecast Xeris Biopharma Holdings Inc.July 2025 Movers & Community Verified Swing Trade Signals - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could be top winner2025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com
Detecting support and resistance levels for Xeris Biopharma Holdings Inc.Market Activity Recap & Accurate Technical Buy Alerts - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock is listed among top recommendationsQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Hits New 1-Year HighStill a Buy? - MarketBeat
Is Xeris Biopharma Holdings Inc. (2B30) stock cheap vs fundamentals2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Xeris Biopharma Hits New 52-Week High of $9.48, Up 297% Year-Over-Year - Markets Mojo
Oppenheimer Adjusts Price Target on Xeris Biopharma to $18 From $8, Maintains Outperform Rating - MarketScreener
What Xeris Biopharma Holdings (XERS)'s Strong Revenue Growth and Pipeline Advances Mean For Shareholders - simplywall.st
How Phase 3 XP-8121 Progress at Xeris Biopharma Holdings (XERS) Has Changed Its Investment Story - Yahoo Finance
Is Xeris Biopharma Holdings Inc a good long term investmentDividend Stock Watch & Superior Trading Portfolio - earlytimes.in
Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):